{"transactions":[{"id":825069,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55283,"kind":"person","name":"Liu James Yang","position":1,"cik":"0001944774","reported_name":"Liu James Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP ACCT, Cntlr, Treasurer, PAO"}}],"security":"Restricted Stock Units","published_at":"2026-03-30T21:29:07.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":6289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU has a value equal to one share of common stock. 33 and 1/3% of the RSUs vested on March 26, 2026 and the remaining 66 and 2/3% will vest in equal installments on each of the second- and third-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each RSU has a value equal to one share of common stock. 33 and 1/3% of the RSUs vested on March 26, 2026 and the remaining 66 and 2/3% will vest in equal installments on each of the second- and third-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each RSU has a value equal to one share of common stock. 33 and 1/3% of the RSUs vested on March 26, 2026 and the remaining 66 and 2/3% will vest in equal installments on each of the second- and third-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date."}],"balance_after":12578,"derivative":{"underlying":"Common Stock","underlying_shares":6289},"source":{"system":"sec-edgar","filing":"0001493152-26-013572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315226013572/ownership.xml","form_type":"4"}},{"id":825068,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55283,"kind":"person","name":"Liu James Yang","position":1,"cik":"0001944774","reported_name":"Liu James Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP ACCT, Cntlr, Treasurer, PAO"}}],"security":"Common Stock","published_at":"2026-03-30T21:29:07.000Z","date":"2026-03-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2578,"price":4.11,"value":10595.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported disposition reflects shares withheld by the Company to cover required tax withholding obligations upon the vesting of the RSUs. The reporting person did not sell any shares."}],"balance_after":3711,"source":{"system":"sec-edgar","filing":"0001493152-26-013572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315226013572/ownership.xml","form_type":"4"}},{"id":825067,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55283,"kind":"person","name":"Liu James Yang","position":1,"cik":"0001944774","reported_name":"Liu James Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP ACCT, Cntlr, Treasurer, PAO"}}],"security":"Common Stock","published_at":"2026-03-30T21:29:07.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":true,"shares":6289,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents vesting of restricted stock units (\"RSUs\") issued pursuant to the Company's 2018 Equity Incentive Plan. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs vested on the one-year anniversary of the effective date of grant."}],"balance_after":6289,"source":{"system":"sec-edgar","filing":"0001493152-26-013572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315226013572/ownership.xml","form_type":"4"}},{"id":1030355,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55283,"kind":"person","name":"Liu James Yang","position":1,"cik":"0001944774","reported_name":"Liu James Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP ACCT, Cntlr, Treasurer, PAO"}}],"security":"Option to Purchase Common Stock","published_at":"2025-09-30T21:01:07.000Z","date":"2025-09-28","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":18000,"derivative":{"exercise_price":3.33,"expiration_date":"2035-09-28","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001493152-25-016360","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225016360/ownership.xml","form_type":"4"}},{"id":1188655,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55283,"kind":"person","name":"Liu James Yang","position":1,"cik":"0001944774","reported_name":"Liu James Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP ACCT, Cntlr, Treasurer, PAO"}}],"security":"Restricted Stock Units","published_at":"2025-03-28T20:05:17.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":18867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33 and 1/3% of the restricted stock units will vest on each of the one-, two- and three-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"33 and 1/3% of the restricted stock units will vest on each of the one-, two- and three-year anniversaries, respectively, of the effective date of grant subject to continuous service through the applicable vesting date."}],"balance_after":18867,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":18867},"source":{"system":"sec-edgar","filing":"0001641172-25-001180","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000164117225001180/ownership.xml","form_type":"4"}},{"id":1188654,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55283,"kind":"person","name":"Liu James Yang","position":1,"cik":"0001944774","reported_name":"Liu James Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP ACCT, Cntlr, Treasurer, PAO"}}],"security":"Option to Purchase Common Stock","published_at":"2025-03-28T20:05:17.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33 and 1/3% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 24 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":3.18,"expiration_date":"2035-03-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001641172-25-001180","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000164117225001180/ownership.xml","form_type":"4"}},{"id":1505054,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55283,"kind":"person","name":"Liu James Yang","position":1,"cik":"0001944774","reported_name":"Liu James Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr Dir., Cntlr, PAO, Int PFO"}}],"security":"Option to Purchase Common Stock","published_at":"2024-05-22T21:18:24.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":10000,"derivative":{"exercise_price":2.76,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-24-021055","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315224021055/ownership.xml","form_type":"4"}},{"id":1760966,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55283,"kind":"person","name":"Liu James Yang","position":1,"cik":"0001944774","reported_name":"Liu James Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr Dir Controller PAO Int PFO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-10-12T20:30:57.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":8482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":8482,"derivative":{"exercise_price":3.11,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":8482},"source":{"system":"sec-edgar","filing":"0001493152-23-037054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223037054/ownership.xml","form_type":"4"}},{"id":2050394,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":55283,"kind":"person","name":"Liu James Yang","position":1,"cik":"0001944774","reported_name":"Liu James Yang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller, PAO"}}],"security":"Option to Purchase Common Stock","published_at":"2023-01-19T22:16:14.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":57065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will become exercisable in three equal installments on each of January 17, 2024, January 17, 2025 and January 17, 2026, subject to continuous service through the applicable vesting date."}],"balance_after":57065,"derivative":{"exercise_price":0.4629,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":57065},"source":{"system":"sec-edgar","filing":"0001493152-23-001944","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223001944/ownership.xml","form_type":"4"}}]}